Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antiangiogenics meet nanotechnology.

Erkki Ruoslahti1

  • 1The Burnham Institute, La Jolla, California 92037, USA. ruoslahti@burnham.org

Cancer Cell
|September 3, 2002
PubMed
Summary

A novel nanoparticle delivery system effectively targets tumor blood vessels using a mutant Raf-1 gene for anti-angiogenic gene therapy in mice.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting the αvβ5 Integrin Modifies the TGF-β-Rich Tumor Microenvironment of Pancreatic Cancer.

Cancer research·2026
Same author

A neuroprotective tetrapeptide for treatment of acute traumatic brain injury.

EMBO molecular medicine·2025
Same author

A Cyclic Peptide Targets Glioblastoma by Binding to Aberrantly Exposed SNAP25.

Molecular pharmaceutics·2024
Same author

A CYCLIC PEPTIDE TARGETS GLIOBLASTOMA BY BINDING TO ABERRANTLY EXPOSED SNAP25.

bioRxiv : the preprint server for biology·2024
Same author

My scientific journey to and through extracellular matrix.

Matrix biology : journal of the International Society for Matrix Biology·2024
Same author

Author Correction: Systemically administered wound-homing peptide accelerates wound healing by modulating syndecan-4 function.

Nature communications·2024

Area of Science:

  • Oncology
  • Nanotechnology
  • Gene Therapy

Background:

  • Angiogenesis is crucial for tumor growth and metastasis.
  • Targeted gene therapy offers a promising approach to inhibit angiogenesis.
  • Developing effective delivery systems for therapeutic genes is essential.

Purpose of the Study:

  • To evaluate the efficacy of a nanoparticle-based gene therapy for anti-angiogenesis.
  • To assess the targeted delivery of a mutant Raf-1 gene to tumor vasculature.
  • To investigate the therapeutic potential of this approach in a mouse model.

Main Methods:

  • A mutant Raf-1 gene was loaded onto nanoparticles.
  • Nanoparticles were functionalized with an integrin-binding compound for targeted delivery.
  • The system was administered to mice with tumors.
  • Anti-angiogenic effects and tumor growth were monitored.

Main Results:

  • The targeted nanoparticles successfully delivered the mutant Raf-1 gene to tumor vasculature.
  • Significant inhibition of tumor angiogenesis was observed.
  • The treatment resulted in reduced tumor growth in the mouse model.

Conclusions:

  • Nanoparticle-mediated delivery of mutant Raf-1 gene is an effective anti-angiogenic strategy.
  • Targeted delivery to tumor vasculature enhances therapeutic efficacy.
  • This approach shows promise for cancer gene therapy.

Related Experiment Videos